ALNY
Alnylam Pharmaceuticals Inc
219.70$
-5.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,437.6 | 172.7 | 79.2 | 51.5 | |
| 156.0 | 68.1 | 75.1 | 106.5 | 155.4 | 135.9 | 128.2 | 92.7 | 96.1 | 98.4 | 114.2 | 78.0 | 51.7 | 58.6 | 42.9 | 49.3 | 42.1 | 30.7 | 29.0 | 29.0 | 30.0 | 24.1 | 22.3 | 19.9 | 25.5 | 28.2 | 21.7 | 19.1 | 13.5 | 13.2 | 9.4 | 13.1 | 16.9 | 13.5 | 14.9 | 17.2 | 19.5 | 14.6 | 10.7 | 8.7 | |
| 5.7 | 3.5 | 5.3 | 6.3 | 10.2 | 6.9 | 6.8 | 6.1 | 6.0 | 5.7 | 6.4 | 4.5 | 5.4 | 8.9 | 9.1 | 12.2 | 13.9 | 14.9 | 17.8 | 23.4 | 29.8 | 34.5 | 49.0 | 100.2 | – | – | – | – | – | – | – | – | 1,093.0 | 451.0 | 303.3 | 168.8 | 267.8 | 68.7 | 42.5 | 30.7 | |
| 155.5 | 67.4 | 77.3 | 104.9 | 156.8 | 129.2 | 124.5 | 89.9 | 92.9 | 94.0 | 106.3 | 67.3 | 46.4 | 56.2 | 41.4 | 47.7 | 41.0 | 30.1 | 28.7 | 28.6 | 29.2 | 23.9 | 22.6 | 20.1 | 25.4 | 28.4 | 22.1 | 19.5 | 13.5 | 13.3 | 9.6 | 13.2 | 16.9 | 13.5 | 14.9 | 17.2 | 19.4 | 14.4 | 10.5 | 8.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 248.4 | – | – | – | – | 333.6 | 84.9 | 48.8 | 35.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 573.2 | 147.5 | 96.6 | 2,201.5 | – | – | – | 282.9 | 116.5 | 71.3 | 76.7 | |
| -5.7% | -11.6% | -9.4% | -6.2% | -4.3% | -4.0% | -4.4% | -5.6% | -7.1% | -9.4% | -7.6% | -4.5% | -4.3% | -3.3% | -3.7% | -5.1% | -4.6% | -4.5% | -4.1% | -3.3% | -3.1% | -3.5% | -3.3% | -3.7% | -2.6% | -2.1% | -2.4% | -2.3% | -0.3% | 0.2% | 0.7% | 1.0% | 0.0% | -0.1% | -0.2% | -0.1% | 0.4% | 0.9% | 1.4% | 1.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 97.6% | 94.0% | 90.6% | 91.4% | 88.6% | 87.8% | 85.3% | 83.2% | 84.2% | 83.2% | 83.3% | 83.3% | 83.4% | 83.6% | 83.4% | 83.8% | 83.7% | 83.6% | 81.2% | 84.0% | 83.0% | 84.0% | 87.0% | 85.4% | 85.6% | 86.0% | 83.6% | 84.0% | 81.7% | 80.9% | 79.7% | |
| -1,078.1% | -900.3% | -716.4% | -680.5% | -674.3% | -556.2% | -582.6% | -573.7% | -807.9% | -1,087.6% | -991.9% | -890.1% | -509.6% | -427.5% | -336.0% | -267.5% | -232.5% | -168.1% | -140.9% | -109.4% | -94.5% | -83.9% | -76.0% | -80.8% | -82.3% | -75.7% | -68.9% | -66.8% | -20.6% | -15.4% | -8.8% | 4.4% | -9.0% | -7.9% | -4.9% | -7.3% | 8.2% | 13.5% | 17.5% | 20.8% | |
| -1,041.2% | -869.6% | -705.1% | -670.8% | -664.7% | -545.9% | -565.2% | -533.5% | -754.1% | -1,016.6% | -929.5% | -848.7% | -485.7% | -403.2% | -310.0% | -245.1% | -222.2% | -174.1% | -153.5% | -129.0% | -111.8% | -101.0% | -101.5% | -110.9% | -123.0% | -109.0% | -93.1% | -86.0% | -29.6% | -24.1% | -16.6% | -3.1% | -15.9% | -12.4% | -11.5% | -13.0% | 1.4% | 8.4% | 13.5% | 16.8% | |
| -886.3% | -789.4% | -703.2% | -656.4% | -664.5% | -541.6% | -568.0% | -515.0% | -681.2% | -920.5% | -863.4% | -348.4% | -219.8% | -190.5% | -158.0% | -252.4% | -193.4% | -139.1% | -117.8% | -95.0% | -92.2% | -85.0% | -74.4% | -74.6% | -65.7% | -59.1% | -52.9% | -43.7% | -3.9% | 2.3% | 6.4% | 13.6% | 0.8% | -1.9% | -3.2% | -2.1% | 6.9% | 12.5% | 15.0% | 11.3% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -38.2% | -44.6% | -49.9% | -39.4% | -43.6% | -27.8% | -29.9% | -35.2% | -46.8% | -58.5% | -51.9% | -48.8% | -51.1% | -61.6% | -65.7% | -60.5% | -73.3% | -84.5% | -94.6% | -103.9% | -110.8% | -145.0% | -222.6% | -557.1% | – | – | – | – | – | – | – | – | -1,027.0% | -414.6% | -233.6% | -127.3% | 18.6% | 39.8% | 53.7% | 59.7% | |
| -29.5% | -32.5% | -36.5% | -30.9% | -34.0% | -24.6% | -27.3% | -31.9% | -41.3% | -48.4% | -39.8% | -31.6% | -32.3% | -37.0% | -38.9% | -25.1% | -26.9% | -25.2% | -26.9% | -25.3% | -24.1% | -23.4% | -26.0% | -29.4% | -33.4% | -31.9% | -31.4% | -31.3% | -13.3% | -11.5% | -8.7% | -1.8% | -7.9% | -6.6% | -6.4% | -7.0% | 0.9% | 6.3% | 11.3% | 14.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -18 | -32 | 129 | -109 | 98 | -604 | -351 | -301 | -287 | -327 | -678 | -1,077 | -895 | -519 | -439 | -547 | -465 | -268 | -149 | -273 | -620 | -104 | 184 | 143 | -16 | 193 | 389 | 403 | 28 | 250 | 382 | 96 | -34 | 100 | 52 | -41 | -405 | -604 | -656 | -651 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.8 | – | – | – | – | -2.2 | -1.0 | -0.7 | -0.6 | |
| 77.3% | 72.9% | 73.3% | 78.3% | 78.0% | 88.6% | 91.2% | 90.6% | 88.2% | 82.7% | 76.8% | 64.7% | 63.2% | 60.1% | 59.2% | 41.5% | 36.7% | 29.8% | 28.5% | 24.3% | 21.8% | 16.1% | 11.7% | 5.3% | -1.9% | -4.5% | -7.6% | -12.0% | -4.3% | -5.8% | -5.7% | -0.1% | 0.8% | 1.6% | 2.7% | 5.5% | 4.8% | 15.9% | 21.0% | 24.4% | |
| 0.1 | 0.2 | 0.4 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.6 | 0.6 | 1.2 | 1.8 | 4.1 | – | – | – | – | – | – | – | – | 32.9 | 15.9 | 9.3 | 4.3 | 4.6 | 1.3 | 1.0 | 0.8 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -4.53 | -4.78 | -4.82 | -5.03 | -5.03 | -5.11 | -5.25 | -5.67 | -6.87 | -7.53 | -7.61 | -7.90 | -7.56 | -7.93 | -7.86 | -7.36 | -7.68 | -7.38 | -7.49 | -7.53 | -7.03 | -7.12 | -7.42 | -8.11 | -9.68 | -9.18 | -8.58 | -8.53 | -3.88 | -3.50 | -2.63 | -0.58 | -2.58 | -2.16 | -2.08 | -2.46 | 0.32 | 2.30 | 4.18 | 5.84 | |
| 0.43 | 0.55 | 0.68 | 0.75 | 0.76 | 0.94 | 0.93 | 1.06 | 0.91 | 0.74 | 0.82 | 0.93 | 1.56 | 1.97 | 2.54 | 3.00 | 3.46 | 4.24 | 4.88 | 5.84 | 6.29 | 7.05 | 7.31 | 7.31 | 7.87 | 8.42 | 9.21 | 9.93 | 13.12 | 14.55 | 15.88 | 18.50 | 16.29 | 17.48 | 18.11 | 18.99 | 23.37 | 27.25 | 31.01 | 34.75 | |
| 11.84 | 10.72 | 9.66 | 12.75 | 11.53 | 18.37 | 17.55 | 16.12 | 14.67 | 12.88 | 14.68 | 16.18 | 14.78 | 12.87 | 11.97 | 12.18 | 10.48 | 8.74 | 7.91 | 7.25 | 6.34 | 4.91 | 3.33 | 1.46 | -0.55 | -1.28 | -2.09 | -3.27 | -1.26 | -1.76 | -1.74 | -0.02 | 0.25 | 0.52 | 0.89 | 1.93 | 1.70 | 5.79 | 7.78 | 9.79 | |
| -3.85 | -4.34 | -4.80 | -4.92 | -5.03 | -5.07 | -5.28 | -5.47 | -6.20 | -6.82 | -7.07 | -3.24 | -3.42 | -3.75 | -4.01 | -7.58 | -6.68 | -5.89 | -5.74 | -5.55 | -5.80 | -6.00 | -5.43 | -5.46 | -5.17 | -4.98 | -4.87 | -4.34 | -0.51 | 0.33 | 1.01 | 2.52 | 0.12 | -0.33 | -0.58 | -0.40 | 1.61 | 3.41 | 4.64 | 3.92 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.